CAMBRIDGE, England--(BUSINESS WIRE)--Cambridge GaN Devices (CGD), the fabless, clean-tech semiconductor company that develops energy-efficient GaN-based power devices that make greener electronics ...

"Wide-bandgap semiconductors like GaN and SiC are being integrated into motor control applications for the power density and efficiency advantages they offer. CGD's ICeGaN technology delivers ease of ...

X-linked chronic granulomatous disease (X-CGD) is a rare genetic disorder characterized by high susceptibility to infections that results from genetic mutations in the cytochrome b-245 beta chain ...

Cambridge GaN Devices (CGD) has signed a tripartite agreement with Chicony Power Technology of Taiwan and Cambridge University Technical Services (CUTS), UK, to develop advanced, high power-density ...

Most of the patients with CGD present during the first 5 years of life. The most commonly involved organs are: skin, lungs, GI tract, lymph nodes, liver, and spleen. An early onset of severe recurrent ...

Cambridge GaN Devices and Qorvo have combined their motor control and power efficiency technologies in the PAC5556A + ICeGaN evaluation kit (EVK). This collaboration combines Qorvo’s high-performance ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. S&P Global Ratings has given a “positive outlook” on Caixa Geral de Depositos, Portugal’s largest bank by ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.